MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression

Biomedicine and Pharmacotherapy

Volumn 75, Issue , 2015, Pages 148-152

  Fang, Baojun ^a,b   Zhu, Jianxin ^a,b   Wang, Yunhua ^b   Geng, Fengyang ^b   Li, Gang ^a  

^a SHANDONG UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Cell cycle; Cell proliferation; Glioblastoma; MiR 454; PDK1

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 454; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN P21; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; 3' UNTRANSLATED REGION; CCND1 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MIRN454 MICRORNA, HUMAN; PDPK1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; ASTROCYTE; CANCER GROWTH; CELL CYCLE ASSAY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MTT ASSAY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; BINDING SITE; BIOLOGY; BRAIN TUMOR; CELL CYCLE CHECKPOINT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES; BINDING SITES; BRAIN NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICRORNAS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84944179314     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.07.029     Document Type: Article

References (19)

1. Sullivan P.R. Brain tumors. N. Engl. J. Med. 2001, 344:1478-1479. author reply 1479.
2. Wang R., Ma Y., Yu D., Zhao J., Ma P. Mir-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ets1. Biomed. Pharmacother. 2015, 70:64-71.
3. Costa P.M., Cardoso A.L., Custodia C., Cunha P., de A., lmeida L., de L., ima M.C. Mirna-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma. J. Control. Release 2015, 207:31-39.
4. Chen H., Li X., Li W., Zheng H. Mir-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of o6-methylguanine-DNA methyltransferase. J. Transl. Med. 2015, 13:69.
5. Wang H., Xu T., Jiang Y., Yan Y., Qin R., Chen J. Micrornas in human glioblastoma: From bench to beside. Front. Biosci. (Landmark ed.) 2015, 20:105-118.
6. Qin C., Huang R.Y., Wang Z.X. Potential role of mir-100 in cancer diagnosis, prognosis, and therapy. Tumour Biol. 2015, 36:1403-1409.
7. Romero-Cordoba S.L., Salido-Guadarrama I., Rodriguez-Dorantes M., Hidalgo-Miranda A. Mirna biogenesis: Biological impact in the development of cancer. Cancer Biol. Ther. 2014, 15:1444-1455.
8. Zhao X.M., Liu K.Q., Zhu G., He F., Duval B., Richer J.M., Huang D.S., Jiang C.J., Hao J.K., Chen L. Identifying cancer-related micrornas based on gene expression data. Bioinformatics (Oxf. Engl.) 2015, 31:1226-1234.
9. Shen F., Cai W.S., Feng Z., Li J.L., Chen J.W., Cao J., Xu B. Mir-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing sox7 expression. Tumour Biol. 2015, 36:1913-1921.
10. Jeansonne D., DeLuca M., Marrero L., Lassak A., Pacifici M., Wyczechowska D., Wilk A., Reiss K., Peruzzi F. Anti-tumoral effects of mir-3189-3p in glioblastoma. J. Biol. Chem. 2015, 290:8067-8080.
11. Wang Z., Ma X., Cai Q., Wang X., Yu B., Cai Q., liu B., Zhu Z., Li C. Mir-199a-3p promotes gastric cancer progression by targeting zhx1. FEBS Lett. 2014, 588:4504-4512.
12. Rosenberg T., Thomassen M., Jensen S.S., Larsen M.J., Sorensen K.P., Hermansen S.K., Kruse T.A., Kristensen B.W. Acute hypoxia induces upregulation of microrna-210 expression in glioblastoma spheroids. CNS Oncol. 2015, 4:25-35.
13. Yang X., Zhang C., Guo T., Feng Y., Liu Q., Chen Y., Zhang Q. Reduced expression of microrna206 regulates cell proliferation via cyclind2 in gliomas. Mol. Med. Rep. 2015, 11:3295-3300.
14. Clarke B.D., Roby J.A., Slonchak A., Khromykh A.A. Functional non-coding rnas derived from the flavivirus 3' untranslated region. Virus Res. 2015, 206:53-61.
15. Kim Y., Yeo J., Lee J.H., Cho J., Seo D., Kim J.S., Kim V.N. Deletion of human tarbp2 reveals cellular microrna targets and cell-cycle function of trbp. Cell Rep. 2014, 9:1061-1074.
16. Morais D.R., Reis S.T., Viana N., Piantino C.B., Massoco C., Moura C., Dip N., Silva I.A., Srougi M., Leite K.R. The involvement of mir-100 in bladder urothelial carcinogenesis changing the expression levels of mrna and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability. Cancer cell Int. 2014, 14:119.
17. Liu S.G., Qin X.G., Zhao B.S., Qi B., Yao W.J., Wang T.Y., Li H.C., Wu X.N. Differential expression of mirnas in esophageal cancer tissue. Oncol. Lett. 2013, 5:1639-1642.
18. Wada M., Horinaka M., Yasuda S., Masuzawa M., Sakai T., Katoh N. Pdk1 is a potential therapeutic target against angiosarcoma cells. J. Dermatol. Sci. 2015, 78:44-50.
19. Yang Z., Wu Z., Liu T., Han L., Wang C., Yang B., Zheng F. Upregulation of pdk1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro. Med. Oncol. (Northwood Lond. Engl.) 2014, 31:337.